These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6420386)

  • 1. The myxopyronins, new inhibitors of bacterial RNA synthesis from Myxococcus fulvus (Myxobacterales).
    Irschik H; Gerth K; Höfle G; Kohl W; Reichenbach H
    J Antibiot (Tokyo); 1983 Dec; 36(12):1651-8. PubMed ID: 6420386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The myxovalargins, new peptide antibiotics from Myxococcus fulvus (Myxobacterales). I. Cultivation, isolation, and some chemical and biological properties.
    Irschik H; Gerth K; Kemmer T; Steinmetz H; Reichenbach H
    J Antibiot (Tokyo); 1983 Jan; 36(1):6-12. PubMed ID: 6432761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The corallopyronins, new inhibitors of bacterial RNA synthesis from Myxobacteria.
    Irschik H; Jansen R; Höfle G; Gerth K; Reichenbach H
    J Antibiot (Tokyo); 1985 Feb; 38(2):145-52. PubMed ID: 2581926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ripostatins, novel inhibitors of eubacterial RNA polymerase isolated from myxobacteria.
    Irschik H; Augustiniak H; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1995 Aug; 48(8):787-92. PubMed ID: 7592022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tartrolons, new boron-containing antibiotics from a myxobacterium, Sorangium cellulosum.
    Irschik H; Schummer D; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1995 Jan; 48(1):26-30. PubMed ID: 7532644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The myxalamids, new antibiotics from Myxococcus xanthus (Myxobacterales). I. Production, physico-chemical and biological properties, and mechanism of action.
    Gerth K; Jansen R; Reifenstahl G; Höfle G; Irschik H; Kunze B; Reichenbach H; Thierbach G
    J Antibiot (Tokyo); 1983 Sep; 36(9):1150-6. PubMed ID: 6415031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The myxovirescins, a family of antibiotics from Myxococcus virescens (Myxobacterales).
    Gerth K; Irschik H; Reichenbach H; Trowitzsch W
    J Antibiot (Tokyo); 1982 Nov; 35(11):1454-9. PubMed ID: 6819280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sorangicins, novel and powerful inhibitors of eubacterial RNA polymerase isolated from myxobacteria.
    Irschik H; Jansen R; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1987 Jan; 40(1):7-13. PubMed ID: 3104268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myxothiazol, an antibiotic from Myxococcus fulvus (myxobacterales). I. Cultivation, isolation, physico-chemical and biological properties.
    Gerth K; Irschik H; Reichenbach H; Trowitzsch W
    J Antibiot (Tokyo); 1980 Dec; 33(12):1474-9. PubMed ID: 6788741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring chemical diversity of α-pyrone antibiotics: molecular basis of myxopyronin biosynthesis.
    Sucipto H; Wenzel SC; Müller R
    Chembiochem; 2013 Sep; 14(13):1581-9. PubMed ID: 23983106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autocides produced by Myxococcus xanthus.
    Varon M; Cohen S; Rosenberg E
    J Bacteriol; 1984 Dec; 160(3):1146-50. PubMed ID: 6438061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Saframycin Mx1, a new natural saframycin isolated from a myxobacterium.
    Irschik H; Trowitzsch-Kienast W; Gerth K; Höfle G; Reichenbach H
    J Antibiot (Tokyo); 1988 Aug; 41(8):993-8. PubMed ID: 2459096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection].
    Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New pyrrolizidinone antibiotics CJ-16,264 and CJ-16,367.
    Sugie Y; Hirai H; Kachi-Tonai H; Kim YJ; Kojima Y; Shiomi Y; Sugiura A; Sugiura A; Suzuki Y; Yoshikawa N; Brennan L; Duignan J; Huang LH; Sutcliffe J; Kojima N
    J Antibiot (Tokyo); 2001 Nov; 54(11):917-25. PubMed ID: 11827034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro antibacterial activity of depsidone chlorate 1'-chloropannarine].
    Díaz B; Ugarte R; Quilhot W; Vera A; Gambaro V
    Rev Latinoam Microbiol; 1988; 30(2):79-86. PubMed ID: 3217629
    [No Abstract]   [Full Text] [Related]  

  • 16. Indiacens A and B: prenyl indoles from the myxobacterium Sandaracinus amylolyticus.
    Steinmetz H; Mohr KI; Zander W; Jansen R; Gerth K; Müller R
    J Nat Prod; 2012 Oct; 75(10):1803-5. PubMed ID: 23035772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 18. Biological activity of an antibiotic produced by Myxococcus coralloides.
    Arias JM; Rodriguez C; Montoya E
    Microbios; 1979; 24(96):123-31. PubMed ID: 120482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korormicin, a novel antibiotic specifically active against marine gram-negative bacteria, produced by a marine bacterium.
    Yoshikawa K; Takadera T; Adachi K; Nishijima M; Sano H
    J Antibiot (Tokyo); 1997 Nov; 50(11):949-53. PubMed ID: 9592569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic activity of myxobacteria in relation to their bacteriolytic capacity.
    NOREN B; RAPER KB
    J Bacteriol; 1962 Jul; 84(1):157-62. PubMed ID: 14480333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.